UBS O'Connor’s Hi-Crush Inc. Common Stock HCR Stock Holding History

UBS O'Connor’s Portfolio HCR Stock Details HCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-35,000	Closed	-$607K	–	514
2017 Q1	$607K	Buy	+35,000	New	+$647K	0.01%	357

Other funds holding HCR

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

LCM

Lafitte Capital Management Austin, Texas $49.5M AUM 27.1% 1-Year Est. Return

UBS O'Connor's HCR Position: Q2 2017 in Review

UBS O'Connor sold out of Hi-Crush Inc. Common Stock (HCR) in Q2 2017, closing a stake of 35,000 shares — an estimated $607K sold.

UBS O'Connor first reported a position in HCR in Q1 2017 and held it in 1 quarter. The position peaked at $607K in Q1 2017. 107 funds tracked by Wall St. Rank hold HCR as of Q2 2017.

UBS O'Connor reported no remaining Hi-Crush Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
UBS O'Connor sold 35,000 Hi-Crush Inc. Common Stock shares in Q2 2017, an estimated $607K.
UBS O'Connor first reported a position in Hi-Crush Inc. Common Stock in Q1 2017 and held it in 1 quarter.
UBS O'Connor's Hi-Crush Inc. Common Stock position peaked at $607K in Q1 2017.
107 funds tracked by Wall St. Rank held Hi-Crush Inc. Common Stock as of Q2 2017.

Based on UBS O'Connor's 13F filing for Q2 2017, filed 14 Aug 2017.